For the first time ever, Health Canada has approved a drug designed to treat postpartum depression. Zurzuvae is a pill that has already been authorized for use in the United States, the U.K. and the EU. Nathaniel Dove has this story and more in Health Matters for Dec. 9, 2025.
Health Matters
Health Matters: Canada approves drug for postpartum depression
More Videos
-
Health Matters: 4 people hospitalized after Pillsbury Pizza Pops recalled due to E. Coli concerns
-
Health Matters: Pillsbury brand Pizza Pops recalled due to E. coli concerns
-
Health Matters: New regulations targeting illegal drug chemicals, equipment
-
Health Matters: Eli Lilly says new oral pill helps maintain weight loss
-
Flu cases surge across Canada with H3N2 as the dominant strain of the virus
-
Health Matters: Flu season spiking ahead of holiday season, experts say
You are viewing an Accelerated Mobile Webpage.
View Original Article